BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
345 hedge funds and large institutions have $5.86B invested in Blueprint Medicines in 2024 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 148 increasing their positions, 99 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
8% more funds holding
Funds holding: 319 → 345 (+26)
2.59% more ownership
Funds ownership: 103.12% → 105.71% (+2.6%)
3% less capital invested
Capital invested by funds: $6.04B → $5.86B (-$189M)
Holders
345
Holding in Top 10
8
Calls
$148M
Puts
$131M
Top Buyers
| 1 | +$109M | |
| 2 | +$52.4M | |
| 3 | +$47M | |
| 4 |
Jennison Associates
New York
|
+$33M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$30.1M |
Top Sellers
| 1 | -$208M | |
| 2 | -$77.2M | |
| 3 | -$38M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$24.3M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$23M |